目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Allergic Rhinitis Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Awareness About Allergies and Available Treatment Options
3.2.1.2 Increasing Prevalence of Respiratory Disorders
3.2.1.3 Launch of Effective and Novel Drug Delivery Systems
3.2.2 Market Restraining Factors
3.2.2.1 Adverse Effects of Drugs Used in Treatment of Allergic Rhinitis
3.2.2.2 Similarity of Symptoms with Other Diseases
3.2.3 Market Opportunities
3.2.3.1 Increasing Advancements in Allergen Immunotherapy (AIT)
3.2.3.2 Favourable Government Initiatives to Promote Awareness Regarding Allergic Rhinitis
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Allergic Rhinitis Drugs Market Analysis by Treatment Type
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
4.4 Antihistamines
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Immunotherapy
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Sublingual immunotherapy (SLIT)
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Sublingual immunotherapy (SLIT)
4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.6 Corticosteroids
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Decongestants
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Others
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Allergic Rhinitis Drugs Market Analysis by Disease Type
5.1 Key Findings
5.2 Product Segment: Market Attractiveness Index
5.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease Type
5.4 Seasonal Allergic Rhinitis
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Perennial Allergic Rhinitis
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Occupational Allergic Rhinitis
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Allergic Rhinitis Drugs Market Analysis by Route of Administration
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
6.4 Oral
6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Nasal
6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Intraocular
6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Intravenous
6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Allergic Rhinitis Drugs Market Analysis by Distribution Channel
7.1 Key Findings
7.2 Product Segment: Market Attractiveness Index
7.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
7.4 Retail Pharmacies
7.4.1 Market Size by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Hospital Pharmacies
7.5.1 Market Size by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Online Pharmacies
7.6.1 Market Size by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Allergic Rhinitis Drugs Market Analysis by Region
8.1 Key Findings
8.2 Regional Segment: Market Attractiveness Index
8.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast

9 North America Allergic Rhinitis Drugs Market Analysis
9.1 Key Findings
9.2 North America Allergic Rhinitis Drugs Market Attractiveness Index
9.3 North America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
9.5 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
9.6 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
9.7 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
9.8 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
9.9 U.S. Allergic Rhinitis Drugs Market Analysis
9.10 Canada Allergic Rhinitis Drugs Market Analysis

10 Europe Allergic Rhinitis Drugs Market Analysis
10.1 Key Findings
10.2 Europe Allergic Rhinitis Drugs Market Attractiveness Index
10.3 Europe Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
10.5 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
10.6 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
10.7 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
10.8 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
10.9 Germany Allergic Rhinitis Drugs Market Analysis
10.10 France Allergic Rhinitis Drugs Market Analysis
10.11 UK Allergic Rhinitis Drugs Market Analysis
10.12 Italy Allergic Rhinitis Drugs Market Analysis
10.13 Spain Allergic Rhinitis Drugs Market Analysis
10.14 Russia Allergic Rhinitis Drugs Market Analysis
10.15 Rest of Europe Allergic Rhinitis Drugs Market Analysis

11 Asia Pacific Allergic Rhinitis Drugs Market Analysis
11.1 Key Findings
11.2 Asia Pacific Allergic Rhinitis Drugs Market Attractiveness Index
11.3 Asia Pacific Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
11.5 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
11.6 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
11.7 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
11.8 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
11.9 Japan Allergic Rhinitis Drugs Market Analysis
11.10 China Allergic Rhinitis Drugs Market Analysis
11.11 India Allergic Rhinitis Drugs Market Analysis
11.12 Australia Allergic Rhinitis Drugs Market Analysis
11.13 South Korea Allergic Rhinitis Drugs Market Analysis
11.14 Rest of Asia Pacific Allergic Rhinitis Drugs Market Analysis

12 Latin America Allergic Rhinitis Drugs Market Analysis
12.1 Key Findings
12.2 Latin America Allergic Rhinitis Drugs Market Attractiveness Index
12.3 Latin America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
12.5 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
12.6 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
12.7 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
12.8 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
12.9 Brazil Allergic Rhinitis Drugs Market Analysis
12.10 Mexico Allergic Rhinitis Drugs Market Analysis
12.11 Rest of Latin America Allergic Rhinitis Drugs Market Analysis

13 MEA Allergic Rhinitis Drugs Market Analysis
13.1 Key Findings
13.2 MEA Allergic Rhinitis Drugs Market Attractiveness Index
13.3 MEA Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
13.5 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
13.6 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
13.7 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
13.8 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
13.9 GCC Allergic Rhinitis Drugs Market Analysis
13.10 South Africa Allergic Rhinitis Drugs Market Analysis
13.11 Rest of MEA Allergic Rhinitis Drugs Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2021
14.2 ALCON AG
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2021
14.2.3.2 R&D, 2017-2021
14.2.3.3 Regional Market Shares, 2021
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 AstraZeneca plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2021
14.3.3.2 R&D, 2017-2021
14.3.3.3 Regional Market Shares, 2021
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Bayer AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2021
14.4.3.2 R&D, 2017-2021
14.4.3.3 Regional Market Shares, 2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Dr Reddy's Laboratories Ltd.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2021
14.5.3.2 R&D, 2017-2021
14.5.3.3 Regional Market Shares, 2021
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 GlaxoSmithKline plc
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2021
14.6.3.2 R&D, 2017-2021
14.6.3.3 Regional Market Shares, 2021
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Johnson & Johnson
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2021
14.7.3.2 R&D, 2017-2021
14.7.3.3 Regional Market Shares, 2021
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Merck & Co.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2021
14.8.3.2 R&D, 2017-2021
14.8.3.3 Regional Market Shares, 2021
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Sanofi SA
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2021
14.9.3.2 R&D, 2017-2021
14.9.3.3 Regional Market Shares, 2021
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Sun Pharmaceutical Industries Limited
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2021
14.10.3.2 R&D, 2017-2021
14.10.3.3 Regional Market Shares, 2021
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Teva Pharmaceutical Industries Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2021
14.11.3.2 R&D, 2017-2021
14.11.3.3 Regional Market Shares, 2021
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Allergic Rhinitis Drugs Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 7 Antihistamines Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 8 Immunotherapy Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 9 SCIT Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 10 SLIT Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Corticosteroids Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 12 Decongestants Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 15 Allergic Rhinitis Drugs Market Forecast by Disease Type , 2023-2033 (US$ million)
Table 16 Seasonal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Perennial Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Occupational Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 19 Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 20 Allergic Rhinitis Drugs Market Forecast by Route of Route of Administration, 2023-2033 (US$ million)
Table 21 Oral Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 22 Nasal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 23 Intraocular Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 24 Intravenous Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 26 Retail Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 27 Hospital Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 28 Online Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 29 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 30 North America Allergic Rhinitis Drugs Market Forecast by Country
Table 31 North America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 North America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 North America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 North America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 U.S. Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 36 Canada Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR %, CAGR %)
Table 37 Europe Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 38 Europe Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Europe Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Europe Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 41 Europe Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Germany Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 France Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 UK Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Italy Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 Spain Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Russia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Rest of Europe Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Asia Pacific Allergic Rhinitis Drugs Market forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 50 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 Japan Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Table 55 China Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 India Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 Australia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 South Korea Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Table 59 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 Latin America Allergic Rhinitis Drugs Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 Latin America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 62 Latin America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 63 Latin America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 64 Latin America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 65 Brazil Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 66 Mexico Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 67 Rest of Latin America Allergic Rhinitis Drugs Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 68 MEA Allergic Rhinitis Drugs forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 69 MEA Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 70 MEA Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 71 MEA Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 72 MEA Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 73 GCC Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 74 South Africa Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 75 Rest of MEA Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 76 Alcon AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Alcon AG: Product Benchmarking
Table 78 Alcon AG.: Strategic Outlook
Table 79 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 AstraZeneca plc: Product Benchmarking
Table 81 AstraZeneca plc: Strategic Outlook
Table 82 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Bayer AG.: Product Benchmarking
Table 84 Bayer AG: Strategic Outlook
Table 85 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 87 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
Table 88 GlaxoSmithKline plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 GlaxoSmithKline plc.: Product Benchmarking
Table 90 GlaxoSmithKline plc: Strategic Outlook
Table 91 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Johnson & Johnson: Product Benchmarking
Table 93 Johnson & Johnson: Strategic Outlook
Table 94 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co.: Product Benchmarking
Table 96 Merck & Co.: Strategic Outlook
Table 97 Sanofi SA.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Sanofi SA: Product Benchmarking
Table 99 Sanofi SA : Strategic Outlook
Table 100 Sun Pharmaceutical Industries Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Sun Pharmaceutical Industries Limited: Product Benchmarking
Table 102 Sun Pharmaceutical Industries Limited: Strategic Outlook
Table 103 Teva Pharmaceutical Industries Ltd.: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 105 Teva Pharmaceutical Industries Ltd.: Strategic Outlook

List of Figures
Figure 1 Allergic Rhinitis Drugs Market Segmentation
Figure 2 Allergic Rhinitis Drugs Market by Treatment type: Market Attractiveness Index
Figure 3 Allergic Rhinitis Drugs Market Attractiveness Index by Disease type
Figure 4 Allergic Rhinitis Drugs Market Attractiveness Index by Route of Administration
Figure 5 Allergic Rhinitis Drugs Market Attractiveness Index by Distribution Channel
Figure 6 Allergic Rhinitis Drugs Market Attractiveness Index by Region
Figure 7 Allergic Rhinitis Drugs Market: Market Dynamics
Figure 8 COVID Impact Analysis: Allergic Rhinitis Drugs Market Recovery Scenarios
Figure 9 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 10 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 11 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 12 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 13 Allergic Rhinitis Drugs Market: Porter’s Five Forces Analysis
Figure 14 Allergic Rhinitis Drugs Market: PEST Analysis
Figure 15 Allergic Rhinitis Drugs Market by Treatment Type: Market Attractiveness Index
Figure 16 Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 17 Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023-2033 (%)
Figure 18 Antihistamines Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Antihistamines Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Immunotherapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Immunotherapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 SCIT Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 SCIT Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 SLIT Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 SLIT Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Corticosteroids Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Corticosteroids Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Decongestants Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Decongestants Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 31 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Allergic Rhinitis Drugs Market by Disease Type: Market Attractiveness Index
Figure 33 Allergic Rhinitis Drugs Market Share Forecast by Disease Type, 2023-2033 (%)
Figure 34 Seasonal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 35 Seasonal Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Perennial Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 37 Perennial Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Occupational Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 39 Occupational Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Allergic Rhinitis Drugs Market by Route of Administration: Market Attractiveness Index
Figure 41 Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023-2033 (%)
Figure 42 Oral Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 43 Oral Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Nasal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 45 Nasal Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Intraocular Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 47 Intraocular Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Intravenous Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 49 Intravenous Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Allergic Rhinitis Drugs Market by Distribution Channel: Market Attractiveness Index
Figure 51 Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 52 Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023-2033 (%)
Figure 53 Retail Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 54 Retail Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Hospital Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 56 Hospital Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Online Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 58 Online Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 Allergic Rhinitis Drugs Market by Region: Market Attractiveness Index
Figure 60 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn)
Figure 61 Allergic Rhinitis Drugs Market Share Forecast by Region 2023, 2033(%)
Figure 62 North America Allergic Rhinitis Drugs Market Attractiveness Index
Figure 63 North America Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 64 North America Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 65 North America Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 66 North America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 67 North America Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 68 North America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 69 North America Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 70 North America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 71 North America Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 72 North America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 73 North America Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 74 U.S. Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 75 Canada Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Europe Allergic Rhinitis Drugs Market Attractiveness Index
Figure 77 Europe Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 78 Europe Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 79 Europe Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 80 Europe Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 81 Europe Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 82 Europe Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 83 Europe Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 84 Europe Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 85 Europe Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 86 Europe Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 87 Europe Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 88 Germany Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 France Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 UK Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Italy Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 92 Spain Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 93 Russia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Rest of Europe Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 95 Asia Pacific Allergic Rhinitis Drugs Market Attractiveness Index
Figure 96 Asia Pacific Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 97 Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 98 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 99 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 100 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 101 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 102 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 103 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 104 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 105 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 106 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 107 Japan Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 108 China Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 109 India Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 Australia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 South Korea Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Latin America Allergic Rhinitis Drugs Market Attractiveness Index
Figure 114 Latin America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 115 Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 116 Latin America Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 117 Latin America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 118 Latin America Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 119 Latin America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 120 Latin America Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 121 Latin America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 122 Latin America Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 123 Latin America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 124 Latin America Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 125 Brazil Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 126 Mexico Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 127 Rest of Latin America Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 128 MEA Allergic Rhinitis Drugs Market Attractiveness Index
Figure 129 MEA Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 130 MEA Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 131 MEA Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 132 MEA Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 133 MEA Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 134 MEA Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 135 MEA Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 136 MEA Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 137 MEA Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 138 MEA Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 139 MEA Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 140 GCC Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 141 South Africa Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Rest of MEA Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 143 Company Share Analysis, 2021
Figure 144 Alcon AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 Alcon AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 146 Alcon AG: Regional Market Shares, 2021
Figure 147 AstraZeneca plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 AstraZeneca plc; R&D, 2017-2021 (US$ million, AGR%)
Figure 149 AstraZeneca plc: Regional Market Shares, 2021
Figure 150 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 151 Bayer AG.: R&D, 2017-2021 (US$ million, AGR%)
Figure 152 Bayer AG.: Regional Market Shares, 2021
Figure 153 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 154 Dr. Reddy’s Laboratories Ltd.; R&D, 2017-2021 (US$ million, AGR%)
Figure 155 Dr. Reddy’s Laboratories Ltd.: Regional Market Shares, 2021
Figure 156 GlaxoSmithKline plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 157 GlaxoSmithKline plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 158 GlaxoSmithKline plc: Regional Market Shares, 2021
Figure 159 Johnson & Johnson: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Johnson & Johnson.: R&D, 2017-2021 (US$ million, AGR%)
Figure 161 Johnson & Johnson.: Regional Market Shares, 2021
Figure 162 Merck & Co.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 163 Merck & Co.: R&D, 2017-2021 (US$ million, AGR%)
Figure 164 Merck & Co.: Regional Market Shares, 2021
Figure 165 Sanofi SA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 166 Sanofi SA.: R&D, 2017-2021 (US$ million, AGR%)
Figure 167 Sanofi.: Regional Market Shares, 2021
Figure 168 Sun Pharmaceutical Industries Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 169 Sun Pharmaceutical Industries Limited.: R&D, 2017-2021 (US$ million, AGR%)
Figure 170 Sun Pharmaceutical Industries Limited.: Regional Market Shares, 2021
Figure 171 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 172 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2021